Loratadine

CLINICAL USE

Antihistamine:Symptomatic relief of allergy such as hay fever, urticaria

DOSE IN NORMAL RENAL FUNCTION

10 mg daily

PHARMACOKINETICS

  • Molecular weight                           :382.9
  • %Protein binding                           :97–99
  • %Excreted unchanged in urine     : 40
  • Volume of distribution (L/kg)       :No data
  • half-life – normal/ESRD (hrs)      :12–15/Unchanged

    DOSE IN RENAL IMPAIRMENT

    GFR (mL/MIN)

  • 20 to 50     : Dose as in normal renal function
  • 10 to 20     : Dose as in normal renal function
  • <10           : Dose as in normal renal function

    DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES

  • CAPD                :Not dialysed. Dose as in normal renal function
  • HD                     :Not dialysed. Dose as in normal renal function
  • HDF/high flux   :Unknown dialysability. Dose as in normal renal function
  • CAV/VVHD      :Unlikely to be dialysed. Dose as in normal renal function

    IMPORTANT DRUG INTERACTIONS

    Potentially hazardous interactions with other drugs

  • Antibacterials: concentration possibly increased by erythromycin
  • Antifungals: concentration of loratadine possibly increased by ketoconazole – avoid concomitant use
  • Antivirals: concentration possibly increased by amprenavir – avoid concomitant use; concentration possibly increased by ritonavir

    ADMINISTRATION

    Reconstition

    Route

    Oral

    Rate of Administration

    Comments

    OTHER INFORMATION

    Patients with renal impairment are at increased risk of sedation.

  • Related News